We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$12.3M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.9M
3
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10.4M
4
TSLA icon
Tesla
TSLA
+$9.96M
5
NVDA icon
NVIDIA
NVDA
+$8.73M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$10.4M
2
AVGO icon
Broadcom
AVGO
+$9.33M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.68M
4
DESP
Despegar.com
DESP
+$7.15M
5
ORCL icon
Oracle
ORCL
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNPS icon
1326
CALL
Synopsys
SNPS
$79.7B
– –
-800
Closed -$343K
SO icon
1327
CALL
Southern Company
SO
$107B
– –
-14,500
Closed -$1.33M
SPG icon
1328
PUT
Simon Property Group
SPG
$72.3B
– –
-2,000
Closed -$332K
SPSB icon
1329
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.7B
– –
-17,409
Closed -$524K
SRI icon
1330
Stoneridge
SRI
$213M
– –
-20,900
Closed -$95.9K
SRTS icon
1331
Sensus Healthcare
SRTS
$50.5M
– –
-11,986
Closed -$56.7K
SRZNW icon
1332
Surrozen Inc Warrant
SRZNW
$8.86K
– –
-24,614
Closed -$738
STAG icon
1333
STAG Industrial
STAG
$7.19B
– –
-8,920
Closed -$322K
STIM icon
1334
Neuronetics
STIM
$166M
– –
-20,010
Closed -$73.6K
STT icon
1335
State Street
STT
$50.7B
– –
-3,681
Closed -$330K
STZ icon
1336
Constellation Brands
STZ
$23.2B
– –
-1,280
Closed -$235K
SVRA icon
1337
Savara
SVRA
$1.19B
– –
-256,594
Closed -$711K
SWTX
1338
CALL
DELISTED
SpringWorks Therapeutics
SWTX
– –
-8,300
Closed -$366K
SYF icon
1339
Synchrony
SYF
$25.6B
– –
-10,313
Closed -$546K
TAL icon
1340
TAL Education Group
TAL
$6.87B
– –
-26,042
Closed -$344K
TAP icon
1341
Molson Coors Class B
TAP
$8.09B
– –
-5,794
Closed -$353K
TBI
1342
Trueblue
TBI
$311M
– –
-13,500
Closed -$71.7K
TBT icon
1343
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$312M
– –
-15,190
Closed -$511K
TCOM icon
1344
Trip.com Group
TCOM
$29.1B
– –
-92,083
Closed -$5.85M
TDC icon
1345
Teradata
TDC
$2.55B
– –
-9,738
Closed -$219K
TDS icon
1346
CALL
Telephone and Data Systems
TDS
$3.75B
– –
-10,900
Closed -$422K
TERN
1347
DELISTED
Terns Pharmaceuticals
TERN
– –
-17,500
Closed -$48.3K
TFX icon
1348
Teleflex
TFX
$5.98B
– –
-1,575
Closed -$218K
TG icon
1349
Tredegar Corp
TG
$310M
– –
-12,400
Closed -$95.5K
TH icon
1350
Target Hospitality
TH
$1.64B
– –
-16,918
Closed -$111K
52 53
54
55 56

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.